Picture of Metacrine logo

MTCR — Metacrine News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Metacrine, Inc. reports results for the quarter ended in March - Earnings Summary

* Metacrine, Inc.  MTCR.OQ  reported a quarterly adjusted loss
of 57 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 51 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Metacrine, Inc.'s reported EPS for the quarter was a loss
of 57 cents​.
* The mean earnings estimate of analysts had fallen by
about 1.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Metacrine, Inc. shares had fallen by 42.3% this quarter and
lost 54.5% so far this year.
* The company reported a quarterly loss of $14.77 million.
* Wall Street's median 12-month price target for Metacrine, Inc.
is $19.66 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 01:23 a.m. GMT.
​All figures in US dollars

Recent news on Metacrine

See all news